Detection of Human Cytomegalovirus in Different Histopathological Types of Glioma in Iraqi Patients

Table 3

The distribution of seropositivity for anti-HCMV IgG antibodies among different age classes in glioma patients and control group.

Age class (years)	Glioma patients					Control
	Number	Seropositive		Seronegative		Number	Seropositive		Seronegative
		Number	%	Number	%		Number	%	Number	%
≤20	11	9	81.81	2	18.18	9	6	66.67	3	33.33
21–30	10	8	80	2	20	12	11	91.67	1	8.33
31–40	9	8	88.89	1	11.11	10	7	70	3	30
41–50	11	9	81.81	2	18.18	7	4	57.14	3	42.86
>50	9	8	88.89	1	11.11	2	1	50	1	50